BP Alternative Energy Ventures, part of oil major BP's renewable energy sources division set up in November 2005 to invest $8bn by 2015, and DSM Venturing, which has Netherlands-based industrial group DSM as parent, were the two new investors in Verdezyne.
Verdezyne, a US-based industrial biotech company developing processes for the production of renewable fuels and chemicals formerly known as Coda Genomics, has raised an undisclosed amount from a consortium including two corporate venturing units as new investors.
BP Alternative Energy Ventures, part of oil major BP’s renewable energy sources division set up in November 2005 to invest $8bn by 2015, and DSM Venturing, which has Netherlands-based industrial group DSM as parent, were the two new investors.
They joined a…
